[HTML][HTML] Omicron variant (B. 1.1. 529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?

M Dhawan, ARA Saied, S Mitra, FA Alhumaydhi… - Biomedicine & …, 2022 - Elsevier
Since the start of the COVID-19 pandemic, numerous variants of SARS-CoV-2 have been
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …

Insights into new-onset autoimmune diseases after COVID-19 vaccination

M Guo, X Liu, X Chen, Q Li - Autoimmunity reviews, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …

Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery

L Leng, Z Xu, B Hong, B Zhao, Y Tian, C Wang… - Nature …, 2024 - nature.com
Cepharanthine is a secondary metabolite isolated from Stephania. It has been reported that
it has anti-conronaviruses activities including severe acute respiratory syndrome …

Biomaterials for drug delivery and human applications

P Trucillo - Materials, 2024 - mdpi.com
Biomaterials embody a groundbreaking paradigm shift in the field of drug delivery and
human applications. Their versatility and adaptability have not only enriched therapeutic …

An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines

F Bayani, NS Hashkavaei, S Arjmand, S Rezaei… - Progress in Biophysics …, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that
has caused the recent coronavirus disease (COVID-19) global pandemic. The current …

Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period

D Ao, X He, J Liu, L Xu - Signal transduction and targeted therapy, 2023 - nature.com
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted
in significant casualties and put immense strain on public health systems worldwide, leading …

Advances in the design and delivery of RNA vaccines for infectious diseases

AG Lokras, TR Bobak, SS Baghel, F Sebastiani… - Advanced Drug Delivery …, 2024 - Elsevier
RNA medicines represent a paradigm shift in treatment and prevention of critical diseases of
global significance, eg, infectious diseases. The highly successful messenger RNA (mRNA) …

[HTML][HTML] COVID-19 vaccine hesitancy: umbrella review of systematic reviews and meta-analysis

TA Rahbeni, P Satapathy, R Itumalla… - JMIR Public Health …, 2024 - publichealth.jmir.org
Background The unprecedented emergence of the COVID-19 pandemic necessitated the
development and global distribution of vaccines, making the understanding of global …

Oral vaccines: a better future of immunization

KWY Kwong, Y **n, NCY Lai, JCC Sung, KC Wu… - Vaccines, 2023 - mdpi.com
Oral vaccines are gaining more attention due to their ease of administration, lower
invasiveness, generally greater safety, and lower cost than injectable vaccines. This review …

Research acceleration in self‐driving labs: Technological roadmap toward accelerated materials and molecular discovery

F Delgado-Licona, M Abolhasani - Advanced Intelligent …, 2023 - Wiley Online Library
The urgency of finding solutions to global energy, sustainability, and healthcare challenges
has motivated rethinking of the conventional chemistry and material science workflows. Self …